ZS

@ZSAssociates

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results.

Global
Vrijeme pridruživanja: ožujak 2009.
Rođen/a 1983.

Tweetovi

Blokirali ste korisnika/cu @ZSAssociates

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ZSAssociates

  1. 31. sij

    Building an empowered marketing team asks companies to shift business mindset, process and structure. In part two of this ZS-led panel, industry leaders discuss how to handle the transformation.

    Poništi
  2. 29. sij

    3 market-shaping launch for emerging biopharma companies

    Poništi
  3. 28. sij

    We’re excited to announce the opening of our new office in Washington, D.C. Check out the office leader’s upcoming Kellogg Executive Education course, “High Impact Sales Strategy.”

    Poništi
  4. 28. sij

    How is being leveraged to analyze ? Asheesh Shukla is the next interviewee in ’s “AI &” series.

    Poništi
  5. 27. sij

    Two unconventional ways to achieve product and clinical differentiation:

    Poništi
  6. 24. sij

    Need to scale your program across a global enterprise? Pay attention to these three success factors.

    Poništi
  7. 24. sij

    Most companies agree that patients should be top of mind throughout a drug’s life cycle, but how many have the right tools to become patient-centric? See ZS’s infographic to understand how to transition from concept to capability-building.

    Poništi
  8. 24. sij

    Vijesh Unnikrishnan shares the five actions life sciences companies should take to develop more agile go-to-market strategies for health solutions.

    Poništi
  9. 23. sij

    In an evolving landscape, a strong marketing function can be key to success. Find out what four industry leaders have to say in this ZS-led panel discussion.

    Poništi
  10. 23. sij

    The wave of governance process changes is here. Learn how to ride it:

    Poništi
  11. 23. sij

    In our new video ' associate principal Vijesh Unnikrishnan reviews the importance of ensuring that different customer types know the value of a digital health solution.

    Poništi
  12. 22. sij

    Using to derive insights on drug therapies can potentially improve outcomes while reducing costs. Here’s how.

    Poništi
  13. 20. sij

    brand teams: Here’s why you should be thinking beyond :

    Poništi
  14. 15. sij

    As more emerging biopharma companies prepare to launch specialty drugs designed for targeted populations, ZS’s Judith Kulich and Ben Hohn have seen three market-shaping trends. Learn about the new normal in trends from in

    Poništi
  15. 13. sij

    We’re growing our presence in with ZS’s new office in Cambridge, England. Check out the office leader’s latest insights:

    Poništi
  16. 9. sij

    Four steps to a successful therapeutics launch:

    Poništi
  17. 8. sij

    Learn more about how data is continuing to change the industry in this MD+DI article, featuring thoughts from ZS’s Brian Chapman and other experts.

    Poništi
  18. 7. sij

    The next wave of digital is set to further transform with new ideas and initiatives. Read more in this focused Q&A with ZS and AbbVie leaders.

    Poništi
  19. 7. sij

    ZS’s Victoria Summers shares the seven key POC marketing takeaways from the Industry Summit:

    Poništi
  20. 6. sij

    58% of proactively research patient services, according to ZS’s latest study. Here’s what this could mean for your patient support program:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·